المؤلفون: L. Klimov Ya., T. Vdovina M., V. Pechenkina A., T. Zhelezniakova V., I. Zakharova N., S. Dolbnya V., V. Kuryaninova A., A. Kastarnov V., D. Shmalko A., R. Tsutsaev O., Yu. Bykov V., Л. Климов Я., Т. Вдовина М., В. Печёнкина А., Т. Железнякова В., И. Захарова Н., С. Долбня В., В. Курьянинова А., А. Кастарнов В., Д. Шмалько А., Р. Цуцаев О., Ю. Быков В.

المصدر: Meditsinskiy sovet = Medical Council; № 17 (2021); 226-234 ; Медицинский Совет; № 17 (2021); 226-234 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: osteogenesis imperfecta, congenital fractures, antenatal diagnostics, medical and genetic counselling, rare mutation in COL1A1 gene, несовершенный остеогенез, врожденные переломы, антенатальная диагностика, медико-генетическое консультирование, редкая мутация в гене COL1A1

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/6505/5895; Яхяева Г.Т., Намазова-Баранова Л.С., Маргиева Т.В., Чумакова О.В. Несовершенный остеогенез у детей в Российской Федерации: результаты аудита федерального регистра. Педиатрическая фармакология. 2016;13(1):44-48. https://doi.org/10.15690/pf.v13i1.1514.; Martin E., Shapiro J.R. Osteogenesis Imperfecta: Epidemiology and Pathophysiology. Curr Osteopor Reports. 2007;5(3):91-97. https://doi.org/10.1007/s11914-007-0023-z.; Van Dijk F.S., Sillence D.O. Osteogenesis Imperfecta: Clinical Diagnosis, Nomenclature and Severity Assessment. Am J Med Genet. 2014;164A(6):1470-1481. https://doi.org/10.1002/ajmg.a.36545.; Джонс К.Л. Наследственные синдромы по Дэвиду Смиту: атлассправочник. М.: Практика; 2011. 1022 с.; Kim H.K.W. Metabolic and endocrine bone diseases. In: Herring J.A. (ed.). Tachdjian’s Pediatric Orthopaedics: From the Texas Scottish Rite Hospital for Children. 5th ed. Saunders; 2014, pp. 582-642.; Щеплягина Л.А., Полякова Е.Ю., Белова НА. Несовершенный остеогенез: известные и неизвестные факты. Лечение и профилактика. 2017;(1):5-11. Режим доступа: https://www.lechprof.ru/catalog/article/original_research/osteogenesis_imperfecta_in_children_known_and_unknown_facts.; Land C., Rauch F., Montpetit K., Ruck-Gibis J., Glorieux F.H. Effect of Intravenous Pamidronate Therapy on Functional Abilities and Level of Ambulation in Children with Osteogenesis Imperfecta. J Pediatr. 2006;148(4):456-460. https://doi.org/10.1016/j.jpeds.2005.10.041.; Надыршина Д.Д., Хусаинова Р.И., Хуснутдинова Э.К. Молекулярногенетические основы несовершенного остеогенеза. Медицинская генетика. 2013;12(6):15-23. Режим доступа: https://www.medgen-journal.ru/jour/issue/viewIssue/6/6.; Palomo T., Glorieux F.H., Schoenau E., Rauch F. Body Composition in Children and Adolescents with Osteogenesis Imperfecta. J Pediatrics. 2016;169:232-237. https://doi.org/10.1016/j.jpeds.2015.10.058.; Marini J.C. Osteogenesis Imperfecta. In: Kliegman R.M., Stanton B.F., Geme J.W., Schor N., Behrman R.E. (eds.). Nelson Textbook of Pediatrics. 21st ed. Philadelphia: Elsevier Health Sciences; 2011. p. 2437-2440. Available at: https://www.us.elsevi-erhealth.com/nelson-textbook-of-pediatrics-2-volume-set-9780323529501.html.; Rauch F., Glorieux F.H. Osteogenesis Imperfecta. Lancet. 2004;363(9418): 1377-1385. https://doi.org/10.1016/S0140-6736(04)16051-0.; Кадашева А.Б., Черекаев В.А., Арутюнов Н.В., Галкин М.В. Редкое наблюдение гиперостотического поражения черепа при несовершенном остеогенезе. Вопросы нейрохирургии им. Н.Н. Бурденко. 2010;(2):24-29. Режим доступа: https://elibrary.ru/item.asp?id=15164216.; Поворознюк В.В., Гречанина Е.Я., Балацкая Н.И., Вайда В.М. Несовершенный остеогенез: патогенез, классификация, клиническая картина, лечение. Ортопедия, травматология и протезирование. 2009;(4):110-117. https://doi.org/10.15674/0030-598720094110-117.; Harrington J., Sochett E., Howard A. Update on the Evaluation and Treatment of Osteogenesis Imperfecta. Pediatr Clin North Amer. 2014;61(6):1243-1257. https://doi.org/10.1016/j.pcl.2014.08.010.; Шелестова М.Л., Стыгар А.М., Гус А.И., Холин А.М. Антенатальная ультразвуковая диагностика несовершенного остеогенеза II типа. Ультразвуковая и функциональная диагностика. 2013;(4):66-73. Режим доступа: http://vidar.ru/Article.asp?fid=USFD_2013_4_66.; Медведев М.В. Пренатальная эхография: дифференциальный диагноз и прогноз. 4-е изд. М.: Реал Тайм; 2016. 640 с.; https://www.med-sovet.pro/jour/article/view/6505

الاتاحة: https://www.med-sovet.pro/jour/article/view/6505
https://doi.org/10.21518/2079-701X-2021-17-226-234

المؤلفون: L. Klimov Ya., A. Aksenov G., E. Popova V., L. Pogorelova V., R. Cucaev O., Yu. Bykov V., V. Kashnikov S., D. Bobryshev V., V. Kuryaninova A., M. Stoyan V., A. Pankov D., Л. Климов Я., А. Аксёнов Г., Е. Попова В., Л. Погорелова В., Р. Цуцаев О., Ю. Быков В., В. Кашников С., Д. Бобрышев В., В. Курьянинова А., М. Стоян В., А. Панков Д.

المصدر: Meditsinskiy sovet = Medical Council; № 11 (2018); 76-83 ; Медицинский Совет; № 11 (2018); 76-83 ; 2658-5790 ; 2079-701X ; 10.21518/2079-701X-2018-11

مصطلحات موضوعية: acetaminophen, overdose, acute liver failure, ацетаминофен, передозировка, острая печеночная недостаточность

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/2506/2474; Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (Paracetamol)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf, 2006, 15: 398–405.; Hinson JA, Roberts DW, James LP. Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol, 2010, 196: 369–405.; Reuben A, Tillman H, Fontana RJ, Davern T, McGuire B, Stravitz RT, et al. Outcomes in adults with acute liver failure between 1998 and 2013: An observational cohort study. Ann Intern Med, 2016, 164: 724–732.; Lancaster EM, Hiatt JR, Zarrinpar A. Acetaminophen hepatotoxicity: An updated review. Archives of toxicology, 2015, 89: 193–199.; Clark R, Fisher JE, Sketris IS, Johnston GM. Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combinations: an observational study. BMC clinical pharmacology, 2012, 12: 11.; Rajanayagam J, Bishop JR, Lewindon PJ, Evans HM. Paracetamol-associated acute liver failure in Australian and New Zealand children: high rate of medication errors. Arch Dis Child, 2015, 100(1): 77–80.; Kliegman R, Behrman R, Jenson Н, Stanton B. Nelson Textbook of Pediatrics. 18. Philadelphia: Saunders Elsevier, 2007.; Olson KR, Davarpanah AH, Schaefer EA, Elias N, Misdraji J. Case 2-2017. An 18-year-old woman with acute liver failure. N Engl J Med, 2017, 376(3): 268–278.; Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS [et al.] Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology, 2005, 42: 1364–1372.; Клиническая токсикология детей и подростков / Под ред. И.В. Марковой, В.В. Афанасьева, Э.К. Цыбулькина, М.В. Неженцева. СПб.: Интермедика, 1998. Т. 1: 252–261.; Лужников Е.А., Гольдфарб Ю.С., Мусселиус С.Г. Детоксикационная терапия: Руководство для врачей. Серия «Мир медицины». См.: изд-во «Лань», 2000. С. 177.; Гольдфарб Ю.С., Казачков В.И., Мусселиус С.Г. и др. Неотложная терапия острых отравлений и эндотоксикозов: Справочник. Под ред. Е.А. Лужникова. М.: Медицина, 2001: 75–79, 282–293.; Bismuth Ch. Toxicologie Clinique, 5th edition. Paris: Medicine-Science Flammarion, 2000: 92–102.; Danel V, Barriot Р. Les Intoxications Aigues. Collection Intoxications aiguës en reanimation, 1993, 9: 345–35З.; Maes M, Vinken M, Jaeschke H. Experimental models of hepatotoxicity related to acute liver failure. Toxicology and applied pharmacology, 2016, 290: 86–97.; Jaeschke H, Xie Y, McGill MR. Acetaminophen-induced liver injury: from animal models to humans. Journal of clinical and translational hepatology, 2014, 2: 153–61.; Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. The Journal of Pharmacology and Experimental Therapeutics, 1973, 187: 211–217.; Prescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet, 1977, 2: 432–434.; Peterson RG, Rumack BH. Treating acute acetaminophen poisoning with acetylcysteine. JAMA, 1977, 237: 2406–2407.; Daly FF, Fountain JS, Murray L, Graudins A, Buckley NA. Panel of Australian and New Zealand clinical toxicologists guidelines for the management of paracetamol poisoning in Australia and New Zealand – explanation and elaboration. Med J, 2008, 188: 296–301.; Hung OL, Nelson LS. Chapter 15: Acetaminophen. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 2015, 2176.; Roberts LJ, Morrow JD. Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. The pharmacological basis of therapeutics. 2001: 687– 731.; Prescott LF. Paracetamol: Past, present, and future. Am J Ther, 2000, 7(2): 143–148.; McGill MR, Jaeschke H. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res, 2013, 30: 2174–2187.; Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol, 2016, 28: 131–142.; Jaeschke H, Williams CD, Ramachandran A, Bajt ML. Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity. Liver Int, 2012, 32: 8–20.; Jaeschke H, McGill MR, Ramachandran A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev, 2012, 44: 88–106.; McGill MR, Lebofsky M, Norris HR, Slawson MH, Bajt ML, Xie Y, et al. Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications. Toxicology and applied pharmacology, 2013, 269: 240–249.; McGill MR, Yan HM, Ramachandran A, Murray GJ, Rollins DE, Jaeschke H. HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity. Hepatology, 2011, 53: 974–982.; Heard KJ, Green JL, James LP, Judge BS, Zolot L, Rhyee S, et al. Acetaminophen-cysteine adducts during therapeutic dosing and following overdose. BMC Gastroenterology, 2011, 11: 20.; Tirmenstein MA, Nelson SD. Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3’-hydroxyacetanilide, in mouse liver. The Journal of Biological Chemistry, 1989, 264: 9814–9819.; McGill MR, Williams CD, Xie Y, Ramachandran A, Jaeschke H. Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicology and Applied Pharmacology, 2012, 264: 387–394.; Hu J, Ramshesh VK, McGill MR, Jaeschke H, Lemasters JJ. Low dose acetaminophen induces reversible mitochondrial dysfunction associated with transient c-Jun N-terminal kinase activation in mouse liver. Toxicol Sci, 2016 Mar, 150(1): 204–215.; Yuan L, Kaplowitz N. Mechanisms of drug-induced liver injury. Clin Liver Dis, 2013, 17: 507–518.; Bismuth Ch. Toxicologie Clinique, 5e édition. Paris: Médecine-Science Flammarion, 2000: 92–102.; O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology, 1989, 97: 439–445.; Bessems JG, Vermeulen NP. Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues, and protective approaches. Rev Toxicol 2001, 31:55–138.; Hu JJ, Lee MJ, Vapiwala M, Reuhl K, Thomas PE, Yang CS. Sex-related differences in mouse renal metabolism and toxicity of acetaminophen. Toxicol Appl Pharmacol, 1993 Sep, 122: 16–26.; Stern ST, Bruno MK, Hennig GE, Horton RA, Roberts JC, Cohen SD. Contribution of acetaminophen-cysteine to acetaminophen nephrotoxicity in CD-1 mice: I. Enhancement of acetaminophen nephrotoxicity by acetaminophen-cysteine. Toxicol Appl Pharmacol, 2005, 202: 151–159.; Mugford CA, Tarloff JB. The contribution of oxidation and deacetylation to acetaminophen nephrotoxicity in female Sprague-Dawley rats. Toxicol Letters, 1997, 93: 15–22.; https://www.med-sovet.pro/jour/article/view/2506

الاتاحة: https://www.med-sovet.pro/jour/article/view/2506
https://doi.org/10.21518/2079-701X-2018-11-76-83